Infections After Receipt of Bacterially Contaminated Umbilical Cord Blood–Derived Stem Cell Products for Other Than Hematopoietic or Immunologic Reconstitution - United States, 2018
The only Food and Drug Administration (FDA)-approved stem cell products are derived from umbilical cord blood, and their only approved use is hematopoietic and immunologic reconstitution. On Sep 17, 2018, the Texas Department of State Health Services received notification of Enterobacter cloacae and...
Saved in:
Published in | MMWR. Morbidity and Mortality Weekly Report Vol. 67; no. 50; p. 1397 |
---|---|
Main Authors | , , , , , , , , |
Format | Report |
Language | English |
Published |
Atlanta
U.S. Center for Disease Control
21.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The only Food and Drug Administration (FDA)-approved stem cell products are derived from umbilical cord blood, and their only approved use is hematopoietic and immunologic reconstitution. On Sep 17, 2018, the Texas Department of State Health Services received notification of Enterobacter cloacae and Citrobacter freundii bloodstream infections in three patients who had received injections or infusions of non-FDA-approved umbilical cord blood-derived stem cell products processed by Genetech, Inc., and distributed by Liveyon, LLC, for other than hematopoietic or immunologic reconstitution at an outpatient clinic on September 12. Patient isolates of E. cloacae had identical pulsed-field gel electropho...resis patterns, suggesting a common source. As of December 14, CDC has received reports of infections in 12 patients from three states, including the initial Florida and Texas cases: Texas (seven), Florida (four), and Arizona . |
---|---|
ISSN: | 0149-2195 1545-861X |